Using Qube 384, we profiled a panel of NaV inhibitors across species, providing valuable translational insight early in analgesic drug discovery.
Metrion combines robust high-throughput KV7 assay capability with deep expertise in voltage gated potassium ion channels to help biotech and pharma teams advance programmes in pain and epilepsy with confidence.
Metrion delivers scalable KV7 IV profiling with the data quality and scientific support needed to advance ion channel programmes efficiently.
Using Qube 384, we profiled a panel of NaV inhibitors across species, providing valuable translational insight early in analgesic drug discovery.
We explore hNav1.9's unique fast and slow inactivation properties using Qube 384 and QPatch 48 platforms, helping to build more predictive screening assays for state-dependent inhibitors.